tiprankstipranks
Trending News
More News >

Axonics downgraded to Peer Perform from Outperform at Wolfe Research

Wolfe Research downgraded Axonics (AXNX) to Peer Perform from Outperform without a price target. The analyst sees the proposed cash acquisition price of $71 per share from Boston Scientific (BSX) as a fair valuation and great outcome for Axonics shareholders. The firm expects there to be “de minimis friction” delivering the planned first half of 2024 close.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on AXNX:

Disclaimer & DisclosureReport an Issue